Trademark: BREYANZI
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for BREYANZI
We do not have any records of a proof of use for BREYANZI at this moment.
Possible trademark infringements of BREYANZI
Basic Information about BREYANZI
- Serial Number
- 88569196
- Filing Date
- 07 Aug 2019
- Registration Number
- 6834335
- Registration Date
- 30 Aug 2022
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of BREYANZI on the blockchain with WikiTrademarks.io.
- First use of BREYANZI anywhere
- BREYANZI was first used on 05 Feb 2021 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns BREYANZI?
1. JUNO THERAPEUTICS, INC. SEATTLE WA
2. JUNO THERAPEUTICS, INC. SEATTLE WA
3. Celgene Corporation Summit NJ
4. Celgene Corporation Summit NJ
Correspondent
- Marilyn F. Kelly
- Bristol-Myers Squibb Company
- Trademark Dept., Mailstop D4243
- P.O. Box 4000
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io